Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Sep-24 6:14 PM View:  | Lachapelle Robin Chief Operating Officer | Arrivent Biopharma, Inc. (AVBP) | 19-Sep-24 | Option Exercise | 27,566 | $3.28 | $90,481.20 | 6% 491.49K to 519.06K | |
| 31-Jan-24 4:10 PM View: | Healy James Director | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 1,252,310 | -- | -- | 100% 0 to 1.25M | |
| 01-Feb-24 4:47 PM View: | Hillhouse Capital Managemen... 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 3,929,120 | -- | -- | 100% 0 to 3.93M | |
| 31-Jan-24 4:12 PM View: | Orbimed Advisors LLC Director 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase Duplicate | 444,444 | $18.00 | $7,999,990.00 | 17% 2.58M to 3.03M | |
| 31-Jan-24 4:11 PM View: | Gordon Carl L Director 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 2,582,880 | -- | -- | 100% 0 to 2.58M | |
| 31-Jan-24 4:10 PM View: | Healy James Director | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase | 444,444 | $18.00 | $7,999,990.00 | 35% 1.25M to 1.7M | |
| 01-Feb-24 4:47 PM View: | Hillhouse Capital Managemen... 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase | 555,555 | $18.00 | $9,999,990.00 | 14% 3.93M to 4.48M | |
| 31-Jan-24 4:12 PM View: | Orbimed Advisors LLC Director 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion Duplicate | 2,582,880 | -- | -- | 100% 0 to 2.58M | |
| 31-Jan-24 4:11 PM View: | Gordon Carl L Director 10% Owner | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase Duplicate | 444,444 | $18.00 | $7,999,990.00 | 17% 2.58M to 3.03M |
